CSBR vs NEM · P/E 16, rev $56.9M vs P/E 14, rev $22.67B
Champions Oncology Inc (CSBR) versus Newmont Goldcorp Corp (NEM) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Newmont Goldcorp Corp (NEM) is a gold company listed on NYSE.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported NEM revenue for 2025-12-31 was $22.67B. Net income was $7.08B. Revenue was up 21.3% from 2024-12-31 to 2025-12-31. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
Not investment advice. Open the CSBR and NEM stock pages for the full models.
Not investment advice.